Sparfloxacinの抗酸菌感染症治療薬としての可能性
スポンサーリンク
概要
- 論文の詳細を見る
We studied the therapeutic potential of utilizing sparfloxacin (SPFX), a newly developed quinolone, to prevent various mycobacterial infections. The in vitro activity of SPFX as a preventive agent for various mycobacteria was determined using the actual countmethod on Ogawa egg medium. The minimal inhibitory concentrations (MIC<SUB>s</SUB>) of SPFXwere as follows: of loxacin-sensitive M. tuberculosis, 0.16-0332μEg/ml; ofloxacin- resistant M. tuberculosis, 0.63-2.5μEg/ml; M. avium; 0.63-10μEg/ml (MICs were equalor less than 1.25μEg/ml in seven out of 11 strains); M. intracellulare, 2.5-10μEg/ml (MICswere equal or more than 10μ/ml in 17 out of 23 strains); M. kansasii, ≥0.08μg/ml; M. chelonae subsp. abscessus, 1.25μg/ml; M. chelonaesubsp. chelonae, 0.63μg/ml; M. scrofulaceum, μg/ml; M. nonchromogenicum, 1.25μg/ml; M. xenopi, ≥0.08μ/ml; M. gordonae, ≥0.08μg/ml. The average serumconcentrations of SPFX during the period of multiple oral administration (200 mg once aday) were 0.35±0.16μg/ml before administration, 0.67±0.32μg/ml after one hour, 1.13±0.21μEg/ml after two hours, 1.27±0.32μg/ml after four hours and 1.31±0.34μg/ml aftersix hours. These results indicate that SPFX has a strong therapeutic potential to preventinfections due to M. tuberculosis, M. kansasii, M. fortuitum, M. chelonae subsp. chelonae, M. scrofulaceum, M.xenopi and M. gordonae. Moreover, it may be expected to be apromising agent against infections due to ofloxacin-resistant M. tuberculosis, M. aviumand M. nonchromogenicum
論文 | ランダム
- A NORMAL FORM THEOREM FOR ELEMENTARY ANALYSIS
- 量子乱流の普遍的な性質 : 量子乱流と古典乱流の対応 (オイラー方程式の数理 : 渦運動と音波150年)
- 人事部の役割 : 変革主導の役割とサーバント・リーダーの役割 (現代企業の人材マネジメント : 理論と実践)
- Gauss-Seidel反復法に対する前処理の組み合わせによる影響について
- 日本のヲコト点の起源と古代韓国語の点吐との関係